Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
Advertisement

Opinion

Michael Smith

Perth’s billionaire set is piling into this little-known medtech

The value of West Australian nerve repair biotech Orthocell has doubled since September as it beefs up its shareholder bases and prepares to break into the US.

Michael SmithHealth editor

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Western Australia is better known for producing mining magnates than medical breakthroughs, but Perth-based nerve repair company Orthocell has global ambitions for its collagen patches made from Australian pigs.

As Orthocell prepares to break into the United States, the ASX-listed company is attracting some high net-worth interest.

Loading...
Michael Smith is the Health Editor for The Australian Financial Review. He is based in Sydney. Connect with Michael on Twitter. Email Michael at michael.smith@afr.com

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Latest In Healthcare & fitness

Fetching latest articles

Most Viewed In Companies